Search

We asked. You answered. Get advice from members of the MSK community on dealing with and alleviating anxiety.

… Monday, August 26, 2019 Summary After reaching the end of active cancer treatment, some people may assume that going for follow-up tests would be easy. However, the anxiety around having scans can be overwhelming. Anxiety leading up to doctors’ visits and having scans (sometimes referred to as “scanxiety

A new technology shows great promise for imaging and treating advanced forms of prostate cancer.

… Thursday, July 1, 2021 A transformation is coming for patients with prostate cancer , says Memorial Sloan Kettering medical oncologist Michael Morris . Researchers at MSK have helped pioneer major advances that will enable doctors to pinpoint the location of prostate cancer cells more precisely than

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

… Tuesday, May 14, 2013 Summary Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer. This image shows melanocytes – cells that protect the skin from ultraviolet radiation – created in a Memorial Sloan Kettering laboratory using

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.

… Thursday, July 10, 2025 Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer metastasis remains a stubborn threat. Metastasis is the name for cancer that has spread

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.

… Tuesday, September 8, 2015 Summary Memorial Sloan Kettering is pioneering the use of a noninvasive scanning technique that has the power to reveal whether a tumor is responding to a treatment within just a few days after a patient has started a regimen. This new platform from General Electric Healthcare

Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.

… Tuesday, October 9, 2018 Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols. Abbreviated breast MRI provides high diagnostic accuracy with

Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.

… Monday, June 30, 2025 Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute. Harrington Discovery Institute Scholar-Innovator Awards support the development

MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.

… Friday, December 1, 2017 Summary Investigators at Memorial Sloan Kettering are conducting research to figure out how cancer cells are able to escape from the original tumor and hide out in the body. Their ultimate goal is to find ways to prevent metastatic tumors from forming. Cancer metastasis occurs

Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.

… Wednesday, October 1, 2025 People with locally advanced  head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The  U.S. Food and Drug Administration (FDA) has approved the immunotherapy drug  pembrolizumab (Keytruda® ) to

The June 29 edition of “MSK Science Spotlight” will feature chemical biologist Yael David, PhD, “Uncovering Epigenetic Events that Drive Oncogenesis.

… Monday, June 29, 2020 The June 29 edition of “ MSK Science Spotlight ” will feature chemical biologist Yael David, PhD, “Uncovering Epigenetic Events that Drive Oncogenesis.” A member of Sloan Kettering Institute , Dr. David develops and applies methods in chemical biology toward studying epigenetic